MDK and cancer: Furthermore, as compared to healthy controls, patients with several cancers have been shown to exhibit upregulated s‐MDK expression, which is useful as a noninvasive parameter for assessing disease diagnosis and progression [20, 38, 39, 40, 41, 42].